CenSyn is developing a handheld EEG device, PenEEG™, that enables rapid, on-the-go monitoring of brain electrical activity for conditions such as Alzheimer's, traumatic brain injury, and epilepsy. This technology provides clinicians with immediate access to brain health data, facilitating early detection and management of neurological disorders while reducing healthcare costs through improved patient outcomes.
Funding
$2.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NSFounders
Product
Problem
Current methods for monitoring brain electrical activity often rely on cumbersome equipment and lengthy setup times, hindering rapid assessment of neurological conditions in various settings. This can delay diagnosis and management of conditions such as Alzheimer's, traumatic brain injury, epilepsy, stroke, and mental health disorders.
Solution
CenSyn is developing PenEEG™, a handheld EEG device designed for rapid, on-the-go monitoring of brain electrical activity. Paired with a companion iOS application, PenEEG™ wirelessly transmits EEG data for immediate review and analysis. Proprietary machine learning algorithms detect altered mental status, while digital cognitive tests assess cognitive performance. The CenSyn platform aims to make brain health screening more accessible, enabling longitudinal tracking of brain performance and aiding in the screening of conditions such as seizures, burst suppression, concussions, stroke, and mental health disorders.
Target Audience
The primary target audience includes clinicians in intensive care units, sports medicine, neurology, and mental health, as well as researchers and healthcare providers seeking to improve accessibility and efficiency in brain health screening.
Features
- Handheld PenEEG™ device for convenient EEG recording
- Wireless data transmission to iOS application for real-time viewing
- Proprietary machine learning algorithms for detecting altered mental status
- Digital cognitive tests, including SCAT-5 and n-Back, for assessing cognitive performance
- Longitudinal tracking of reaction time, fatigue, and brain performance
- Screening capabilities for status epilepticus, concussion, stroke, and mental health disorders
- Secure data storage with HIPAA compliance